Find Your Funding Opportunity
Notice of Intent to Re-issue PAR-22-167 - Limited Competition: Clinical and Translational Science Award (CTSA) Program: Collaborative and Innovative Acceleration Award (UG3/UH3 Clinical Trial Optional)
Service
|
Source |
Final Application Due Date |
Funding Available
|
Match Required
|
|---|---|---|---|---|
| Health Care |
Federal
HHS |
02-17-2025 | $5.0 M | No Match Required |
-
Service
-
Source
-
Final Application Due Date
-
Funding Available
-
Match Required
Status
- Opportunity Type Discretionary
-
CFDA
93.350 -- National Center for Advancing Translational Sciences
Description
The National Center for Advancing Translational Sciences (NCATS) intends to re-issue the Notice of Funding Opportunity Announcement (PAR-22-167) entitled, �Limited Competition: Clinical and Translational Science Award (CTSA) Program: Collaborative and Innovative Acceleration Award (UG3/UH3 Clinical Trial Optional).� This Notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive projects. The NOFO is expected to be published in the Fall of 2024 with an expected application due date in Winter 2025 . The NOFO will again utilize the UG3/UH3 activity code. Please review the CCIA webpage for more Information.
Eligibility
- IHE
- Local Government
- Non-Profit
- Other
- State Government
- Tribal Government
Key Date(s)
- July 19, 2024: Forecasted Date
- October 18, 2024: Estimated Post Date
- February 17, 2025: Estimated Application Due Date
- October 01, 2025: Estimated Award Date
- December 01, 2025: Estimated Project Start Date